Regentatlantic Capital LLC Laboratory Corp Of America Holdings Transaction History

Regentatlantic Capital LLC

  • $3.34 Billion
  • Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Regentatlantic Capital LLC holds 1,873 shares of LH stock, worth $431,595. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,873
Previous 1,688 10.96%
Holding current value
$431,595
Previous $396,000 3.03%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$204.81 - $262.19 $37,889 - $48,505
185 Added 10.96%
1,873 $384,000
Q2 2022

Aug 15, 2022
BUY
$213.86 - $277.87 $11,976 - $15,560
56 Added 3.43%
1,688 $396,000
Q1 2022

May 02, 2022
SELL
$259.82 - $298.18 $16,628 - $19,083
-64 Reduced 3.77%
1,632 $430,000
Q4 2021

Jan 27, 2022
SELL
$271.6 - $314.21 $271 - $314
-1 Reduced 0.06%
1,696 $533,000
Q3 2021

Nov 15, 2021
BUY
$274.82 - $308.34 $23,909 - $26,825
87 Added 5.4%
1,697 $478,000
Q2 2021

Aug 12, 2021
SELL
$251.87 - $278.14 $5,541 - $6,119
-22 Reduced 1.35%
1,610 $444,000
Q1 2021

Apr 29, 2021
SELL
$204.88 - $255.03 $2,253 - $2,805
-11 Reduced 0.67%
1,632 $416,000
Q4 2020

Feb 04, 2021
BUY
$186.91 - $214.42 $5,981 - $6,861
32 Added 1.99%
1,643 $334,000
Q3 2020

Oct 13, 2020
SELL
$167.03 - $201.3 $3,841 - $4,629
-23 Reduced 1.41%
1,611 $303,000
Q2 2020

Aug 13, 2020
SELL
$113.31 - $182.44 $78,070 - $125,701
-689 Reduced 29.66%
1,634 $271,000
Q1 2020

May 14, 2020
BUY
$104.32 - $195.28 $6,780 - $12,693
65 Added 2.88%
2,323 $294,000
Q4 2019

Feb 04, 2020
SELL
$163.48 - $173.61 $7,683 - $8,159
-47 Reduced 2.04%
2,258 $382,000
Q3 2019

Oct 22, 2019
SELL
$159.77 - $178.1 $18,533 - $20,659
-116 Reduced 4.79%
2,305 $387,000
Q2 2019

Jul 23, 2019
BUY
$144.16 - $172.9 $40,653 - $48,757
282 Added 13.18%
2,421 $419,000
Q1 2019

May 03, 2019
SELL
$123.7 - $156.3 $57,520 - $72,679
-465 Reduced 17.86%
2,139 $327,000
Q4 2018

Jan 30, 2019
BUY
$120.82 - $174.09 $112,725 - $162,425
933 Added 55.83%
2,604 $329,000
Q3 2018

Oct 30, 2018
BUY
$167.67 - $188.27 $6,706 - $7,530
40 Added 2.45%
1,671 $290,000
Q1 2018

Apr 23, 2018
SELL
$161.53 - $178.11 $5,653 - $6,233
-35 Reduced 2.1%
1,631 $264,000
Q3 2017

Oct 25, 2017
BUY
$149.47 - $160.56 $249,017 - $267,492
1,666
1,666 $252,000

Others Institutions Holding LH

# of Institutions
95
Shares Held
1.94M
Call Options Held
0
Put Options Held
0
View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

LH Quotes by TradingView
  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email